Translational PET imaging research
The goal of any early central nervous system (CNS) drug development program is always to test the mechanism and not the molecule in order to support additional research investments in late phase clinical trials. Confirmation that drugs reach their targets using translational positron emission tomogr...
Main Authors: | Richard J. Hargreaves, Eugenii A. Rabiner |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-01-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996113002507 |
Similar Items
-
Molecular Imaging with PET/CT in Oncology
by: Pejman Farde esfehani, et al.
Published: (2012-04-01) -
Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET
by: Yuan Huang, et al.
Published: (2021-09-01) -
Imaging in translational cancer research
by: Felix T. Kurz, et al.
Published: (2022-11-01) -
PET Imaging Radiotracers of Chemokine Receptors
by: Santosh R. Alluri, et al.
Published: (2021-08-01) -
Simulation Study for Designing a Dedicated Cardiac TOF-PET System
by: Sandra Oliver, et al.
Published: (2020-02-01)